FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045780599> ?p ?o ?g. }

• W2045780599 endingPage "75" @default.
• W2045780599 startingPage "75" @default.
• W2045780599 abstract "Letters2 January 2007Successful Thalidomide Treatment of Persistent Chylous Pleural EffusionRachel Pauzner, MD, Haim Mayan, MD, Ana Waizman, MD, Judith Rozenman, MD, and Zvi Farfel, MDRachel Pauzner, MDFrom Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel.Search for more papers by this author, Haim Mayan, MDFrom Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel.Search for more papers by this author, Ana Waizman, MDFrom Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel.Search for more papers by this author, Judith Rozenman, MDFrom Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel.Search for more papers by this author, and Zvi Farfel, MDFrom Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-146-1-200701020-00022 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Disseminated lymphangiomatosis is characterized by proliferation of lymph vessels in soft tissues, viscera, or bones (1). Chylothorax is a serious manifestation and is typically refractory to several interventions, including chemical pleurodesis, surgical ligation of the thoracic duct, pleuroperitoneal shunt, radiation therapy, pleurectomy, chest wall resection, and antiestrogen drug therapy (2). It is associated with a poor prognosis. Interferon, which is antiangiogenic, has been used successfully in life-threatening hemangiomatosis of infancy and in some cases of disseminated lymphangiomatosis (3, 4). Thalidomide has immunomodulatory, anti-inflammatory, and antiangiogenic properties (5). In experimental models, thalidomide inhibits angiogenesis that is induced by vascular endothelial ...References1. Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med. 2000;161:1037-46. [PMID: 10712360] CrossrefMedlineGoogle Scholar2. Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax. 1999;54:254-64. [PMID: 10325903] CrossrefMedlineGoogle Scholar3. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456-63. [PMID: 1489383] CrossrefMedlineGoogle Scholar4. Laverdière C, David M, Dubois J, Russo P, Hershon L, Lapierre JG. Improvement of disseminated lymphangiomatosis with recombinant interferon therapy. Pediatr Pulmonol. 2000;29:321-4. [PMID: 10738021] CrossrefMedlineGoogle Scholar5. Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin Ther. 2003;25:342-95. [PMID: 12749503] CrossrefMedlineGoogle Scholar6. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2002;2:727-39. [PMID: 12360276] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Rachel Pauzner, MD; Haim Mayan, MD; Ana Waizman, MD; Judith Rozenman, MD; Zvi Farfel, MDAffiliations: From Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCorrection: Successful Thalidomide Treatment of Persistent Chylous Pleural Effusion Metrics Cited byLaparoscopy for evaluating mesenteric lymphangiomatosis: A case reportDaratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham’s Lymphangiomatosis: Review of the LiteratureLymphangiomatosis associated with protein losing enteropathy: A case reportNovel molecular pathways in Gorham disease: Implications for treatmentA Pleural Effusion with an Unusual CauseAn 11-Year-Old Boy With Respiratory Failure and Massive Pleural Fluid DrainageRecurrent hemorrhagic pericardial effusion in a child due to diffuse lymphangiohemangiomatosis: a case reportCase 23-2010: Unusual Paraprotein Effects in MGUS — Treat or Not?Diffuse Lymphangiomatosis—A Fatal Case With Atypical Skeletal FeaturesDisseminated bone lymphangiomatosisCorrection: Successful Thalidomide Treatment of Persistent Chylous Pleural Effusion 2 January 2007Volume 146, Issue 1Page: 75-76KeywordsBoneChylothoraxDiagnostic radiologyInterferonsOsteomyelitisPleural effusionSurgical resectionThoraxVascular endothelial growth factorVertebrae ePublished: 2 January 2007 Issue Published: 2 January 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ..." @default.
• W2045780599 created "2016-06-24" @default.
• W2045780599 creator A5001975696 @default.
• W2045780599 creator A5038856123 @default.
• W2045780599 creator A5062840444 @default.
• W2045780599 creator A5068246693 @default.
• W2045780599 creator A5072103499 @default.
• W2045780599 date "2007-01-02" @default.
• W2045780599 modified "2023-10-18" @default.
• W2045780599 title "Successful Thalidomide Treatment of Persistent Chylous Pleural Effusion" @default.
• W2045780599 cites W2050715375 @default.
• W2045780599 cites W2064360454 @default.
• W2045780599 cites W2079294967 @default.
• W2045780599 cites W2095462726 @default.
• W2045780599 cites W2151263416 @default.
• W2045780599 cites W2340893063 @default.
• W2045780599 doi "https://doi.org/10.7326/0003-4819-146-1-200701020-00022" @default.
• W2045780599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17200231" @default.
• W2045780599 hasPublicationYear "2007" @default.
• W2045780599 type Work @default.
• W2045780599 sameAs 2045780599 @default.
• W2045780599 citedByCount "12" @default.
• W2045780599 countsByYear W20457805992013 @default.
• W2045780599 countsByYear W20457805992021 @default.
• W2045780599 countsByYear W20457805992022 @default.
• W2045780599 countsByYear W20457805992023 @default.
• W2045780599 crossrefType "journal-article" @default.
• W2045780599 hasAuthorship W2045780599A5001975696 @default.
• W2045780599 hasAuthorship W2045780599A5038856123 @default.
• W2045780599 hasAuthorship W2045780599A5062840444 @default.
• W2045780599 hasAuthorship W2045780599A5068246693 @default.
• W2045780599 hasAuthorship W2045780599A5072103499 @default.
• W2045780599 hasConcept C126322002 @default.
• W2045780599 hasConcept C141071460 @default.
• W2045780599 hasConcept C142724271 @default.
• W2045780599 hasConcept C161191863 @default.
• W2045780599 hasConcept C181152851 @default.
• W2045780599 hasConcept C2776364478 @default.
• W2045780599 hasConcept C2776853793 @default.
• W2045780599 hasConcept C2776979038 @default.
• W2045780599 hasConcept C2778373633 @default.
• W2045780599 hasConcept C2779609412 @default.
• W2045780599 hasConcept C2779634585 @default.
• W2045780599 hasConcept C3020510925 @default.
• W2045780599 hasConcept C41008148 @default.
• W2045780599 hasConcept C61434518 @default.
• W2045780599 hasConcept C71924100 @default.
• W2045780599 hasConceptScore W2045780599C126322002 @default.
• W2045780599 hasConceptScore W2045780599C141071460 @default.
• W2045780599 hasConceptScore W2045780599C142724271 @default.
• W2045780599 hasConceptScore W2045780599C161191863 @default.
• W2045780599 hasConceptScore W2045780599C181152851 @default.
• W2045780599 hasConceptScore W2045780599C2776364478 @default.
• W2045780599 hasConceptScore W2045780599C2776853793 @default.
• W2045780599 hasConceptScore W2045780599C2776979038 @default.
• W2045780599 hasConceptScore W2045780599C2778373633 @default.
• W2045780599 hasConceptScore W2045780599C2779609412 @default.
• W2045780599 hasConceptScore W2045780599C2779634585 @default.
• W2045780599 hasConceptScore W2045780599C3020510925 @default.
• W2045780599 hasConceptScore W2045780599C41008148 @default.
• W2045780599 hasConceptScore W2045780599C61434518 @default.
• W2045780599 hasConceptScore W2045780599C71924100 @default.
• W2045780599 hasIssue "1" @default.
• W2045780599 hasLocation W20457805991 @default.
• W2045780599 hasLocation W20457805992 @default.
• W2045780599 hasOpenAccess W2045780599 @default.
• W2045780599 hasPrimaryLocation W20457805991 @default.
• W2045780599 hasRelatedWork W1917212938 @default.
• W2045780599 hasRelatedWork W1987921566 @default.
• W2045780599 hasRelatedWork W2011571765 @default.
• W2045780599 hasRelatedWork W2078992283 @default.
• W2045780599 hasRelatedWork W2080038709 @default.
• W2045780599 hasRelatedWork W2093424646 @default.
• W2045780599 hasRelatedWork W2394103234 @default.
• W2045780599 hasRelatedWork W2414173292 @default.
• W2045780599 hasRelatedWork W2587379169 @default.
• W2045780599 hasRelatedWork W3081110406 @default.
• W2045780599 hasVolume "146" @default.
• W2045780599 isParatext "false" @default.
• W2045780599 isRetracted "false" @default.
• W2045780599 magId "2045780599" @default.
• W2045780599 workType "article" @default.